All individual trials at Roger Goldberg, M.D., MBA

0 out of 1

0.0%

$28,945,638

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	Roger Goldberg, M.D., MBA	NCT02354170	Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC) [pACT]	2017-04-27	2532

Download this data